À̴뼿ﺴ¿ø 2023³â Á¦16ȸ ´ëÇÑÇ÷¾×ÇÐȸ Àç»ýºÒ·®ºóÇ÷¿¬±¸È¸ µ¿°è ½ÉÆ÷Áö¾ö : 2023-01-28±³À°ÀÏÀÚ : 2023-01-28
±³À°Àå¼Ò : À̴뼿ﺴ¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°´ç (ÁöÇÏ2Ãþ)
±³À°ÁÖÁ¦ :
2023³â Á¦16ȸ ´ëÇÑÇ÷¾×ÇÐȸ Àç»ýºÒ·®ºóÇ÷¿¬±¸È¸ µ¿°è ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Àç»ýºÒ·®ºóÇ÷¿¬±¸È¸
´ã´çÀÚ : ¹Úº¸¹è
¿¬¶ôó : 02-2148-7361
À̸ÞÀÏ :
pbb892004@naver.com ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 60¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01-28 ´ë°´ç 13:00~13:25 Standard frontline therapy with IST or Allo-HSCT ¹Ú¿ë(°í·ÁÀÇ´ë)
±³À°½Ã°£ 01-28 ´ë°´ç 13:25~13:50 Novel frontline therapy with TPO-RA combination with IST ÀåÁØÈ£(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 01-28 ´ë°´ç 14:05~14:30 Alternative TPO-RA for TPO-RA-refractory ITP ¹Ú¿µÈÆ(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 01-28 ´ë°´ç 14:30~14:55 Non-TPO-RA options for TPO-RA-refractory ITP ½Åµ¿¿±(¼¿ïÀÇ´ë)
±³À°½Ã°£ 01-28 ´ë°´ç 15:10~15:35 Proximal complement inhibitors for PNH ¾È¼¿¬(Àü³²ÀÇ´ë)
±³À°½Ã°£ 01-28 ´ë°´ç 15:35~16:00 Terminal complement inhibitors for PNH ±èÁø¼®(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 01-28 ´ë°´ç 16:15~16:40 What¡¯s new in Aplastic Anemia, PNH ±èÇϳª(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 01-28 ´ë°´ç 16:40~17:05 What¡¯s new in ITP, rare hematologic disease Á¤Çظ²(¿¬¼¼ÀÇ´ë)